BGI Genomics provides a wide range of next generation sequencing services and a broad portfolio of genetic tests for medical institutions, research institutions and other public and private partners.
BGI’s mission is to leverage its genomics expertise in order to advance life science research and improve human health for the benefit of mankind.
BGI has particular strengths in prenatal screening, hereditary cancer screening, testing for rare disease and in aiding precision medicine research and initiatives.
Numerous scientific partners, healthcare providers and pharmaceutical companies have come to rely on BGI’s world leading bio-informatics research and development, large scale computing infrastructure for data output and storage, and proprietary sequencing platforms.
BGI is headquartered in Shenzhen, China, with branches and medical laboratories in major cities including Beijing, Tianjin, Wuhan, Shanghai and Guangzhou. BGI also has offices and laboratories located in Europe, North America and the Asia Pacific region.
BGI currently operates in more than 100 countries and regions and works with more than 3000 medical institutions and more than 300 hospitals. To learn more about our company history, services and product portfolio, watch our short animated video!
New Desktop System. Leveraging the proprietary sequencing technology developed at Complete Genomics, BGI has announced a platform designed as a desktop sequencer for deployment in China. This product is designed to support a variety of sequencing applications.
World-Class NGS Service Capabilities. With regional service laboratories in the US, Europe and China, we offer a wide variety of human, plant, and animal NGS services to empower genomics research.
Committed to Quality. Our CAP-compliant and ISO certified laboratories offer both clinical-grade and research-use services to support our global clients with high-quality results and exceptional customer support.